2m 2m 2m 2m 2m 2m 2m
REPLIMUNE GRP (REPL)
NASDAQ
$10.00+$0.07 (+0.66%)
Price as of Jul 13, 2026 7:58 PM EDT- $922.6MMarket Cap
- -11.92%1-Year Change
- BiotechnologyIndustry
REPLIMUNE GRP (REPL)
$10.00+$0.07 (+0.66%)
REPL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.94 | ||
Change | -$1.05 (-9.60%) | ||
Open | $10.91 | ||
High | $10.91 | ||
Low | $9.79 | ||
Previous Close | $10.99 | ||
Volume | 2,830,049 | ||
30-Day Average Volume | 3,175,711 | ||
1-Week Change | -13.38% | ||
1-Month Change | 11.88% | ||
1-Year Change | -11.92% | ||
3-Year Change | -51.49% | ||
5-Year Change | -71.50% | ||
Fundamentals | |||
Shares Outstanding | 83.9M | ||
Total Assets | $332.4M | ||
Market Cap | $922.6M | ||
Enterprise Value | $796.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$73.2M | ||
Free Cash Flow | -$56.2M | ||
EBIT | -$71.1M | ||
EBITDA | -$70.3M | ||
Net Working Capital | $220.9M | ||
EPS | -$0.77 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -14 | ||
PEG | -25 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 15 : 1 | ||
Last Split Date | 12/01/2010 | ||
Earnings & Revenue